These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease. Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758 [TBL] [Abstract][Full Text] [Related]
43. A short echo proton magnetic resonance spectroscopy study of the left mesial-temporal lobe in first-onset schizophrenic patients. Bartha R; al-Semaan YM; Williamson PC; Drost DJ; Malla AK; Carr TJ; Densmore M; Canaran G; Neufeld RW Biol Psychiatry; 1999 Jun; 45(11):1403-11. PubMed ID: 10356621 [TBL] [Abstract][Full Text] [Related]
44. Comparison of brain N-acetylaspartate levels and serum brain-derived neurotrophic factor (BDNF) levels between patients with first-episode schizophrenia psychosis and healthy controls. Goto N; Yoshimura R; Kakeda S; Moriya J; Hayashi K; Ikenouchi-Sugita A; Umene-Nakano W; Hori H; Ueda N; Korogi Y; Nakamura J Eur Psychiatry; 2011 Jan; 26(1):57-63. PubMed ID: 20434315 [TBL] [Abstract][Full Text] [Related]
45. Proton magnetic resonance spectroscopy in frontotemporal dementia. Coulthard E; Firbank M; English P; Welch J; Birchall D; O'Brien J; Griffiths TD J Neurol; 2006 Jul; 253(7):861-8. PubMed ID: 16845570 [TBL] [Abstract][Full Text] [Related]
46. The effect of antidepressant treatment on N-acetyl aspartate levels of medial frontal cortex in drug-free depressed patients. Gonul AS; Kitis O; Ozan E; Akdeniz F; Eker C; Eker OD; Vahip S Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):120-5. PubMed ID: 16236417 [TBL] [Abstract][Full Text] [Related]
47. Decrease of NAA with aging outside the seizure focus in mesial temporal lobe epilepsy--a proton-MRS study at 3 Tesla. Riederer F; Bittsanský M; Lehner-Baumgartner E; Baumgartner C; Mlynárik V; Gruber S; Moser E; Kaya M; Serles W Brain Res; 2007 Nov; 1179():131-9. PubMed ID: 17936253 [TBL] [Abstract][Full Text] [Related]
48. Magnetic resonance spectroscopic imaging detects abnormalities in normal-appearing frontal lobe of patients with Sturge-Weber syndrome. Batista CE; Chugani HT; Hu J; Haacke EM; Behen ME; Helder EJ; Juhász C J Neuroimaging; 2008 Jul; 18(3):306-13. PubMed ID: 18808656 [TBL] [Abstract][Full Text] [Related]
50. Long-term treatment of rats with haloperidol: lack of an effect on brain N-acetyl aspartate levels. Bustillo J; Barrow R; Paz R; Tang J; Seraji-Bozorgzad N; Moore GJ; Bolognani F; Lauriello J; Perrone-Bizzozero N; Galloway MP Neuropsychopharmacology; 2006 Apr; 31(4):751-6. PubMed ID: 16132064 [TBL] [Abstract][Full Text] [Related]
51. Evidence for glutamatergic neuronal dysfunction in the prefrontal cortex in chronic but not in first-episode patients with schizophrenia: a proton magnetic resonance spectroscopy study. Ohrmann P; Siegmund A; Suslow T; Spitzberg K; Kersting A; Arolt V; Heindel W; Pfleiderer B Schizophr Res; 2005 Mar; 73(2-3):153-7. PubMed ID: 15653258 [TBL] [Abstract][Full Text] [Related]
52. Proton magnetic resonance spectroscopy of the inferior frontal gyrus and thalamus and its relationship to verbal learning task performance in patients with schizophrenia: a preliminary report. Hagino H; Suzuki M; Mori K; Nohara S; Yamashita I; Takahashi T; Kurokawa K; Matsui M; Watanabe N; Seto H; Kurachi M Psychiatry Clin Neurosci; 2002 Oct; 56(5):499-507. PubMed ID: 12193238 [TBL] [Abstract][Full Text] [Related]
53. Reduced N-acetylaspartate in the temporal cortex of rats reared in isolation. Harte MK; Powell SB; Reynolds LM; Swerdlow NR; Geyer MA; Reynolds GP Biol Psychiatry; 2004 Aug; 56(4):296-9. PubMed ID: 15312819 [TBL] [Abstract][Full Text] [Related]
54. Hippocampal neurochemical pathology in patients at first episode of affective psychosis: a proton magnetic resonance spectroscopic imaging study. Blasi G; Bertolino A; Brudaglio F; Sciota D; Altamura M; Antonucci N; Scarabino T; Weinberger DR; Nardini M Psychiatry Res; 2004 Jul; 131(2):95-105. PubMed ID: 15313516 [TBL] [Abstract][Full Text] [Related]
55. A comprehensive review of proton magnetic resonance spectroscopy studies in dementia and Parkinson's disease. Firbank MJ; Harrison RM; O'Brien JT Dement Geriatr Cogn Disord; 2002; 14(2):64-76. PubMed ID: 12145453 [TBL] [Abstract][Full Text] [Related]
56. Grey and white matter differences in brain energy metabolism in first episode schizophrenia: 31P-MRS chemical shift imaging at 4 Tesla. Jensen JE; Miller J; Williamson PC; Neufeld RW; Menon RS; Malla A; Manchanda R; Schaefer B; Densmore M; Drost DJ Psychiatry Res; 2006 Mar; 146(2):127-35. PubMed ID: 16497488 [TBL] [Abstract][Full Text] [Related]
57. Regional metabolic assessment of human brain during development by proton magnetic resonance spectroscopy in vivo and by high-performance liquid chromatography/gas chromatography in autopsy tissue. Hüppi PS; Fusch C; Boesch C; Burri R; Bossi E; Amato M; Herschkowitz N Pediatr Res; 1995 Feb; 37(2):145-50. PubMed ID: 7731750 [TBL] [Abstract][Full Text] [Related]
58. Mesial temporal lobe epilepsy: a proton magnetic resonance spectroscopy study and a histopathological analysis. Cohen-Gadol AA; Pan JW; Kim JH; Spencer DD; Hetherington HH J Neurosurg; 2004 Oct; 101(4):613-20. PubMed ID: 15481715 [TBL] [Abstract][Full Text] [Related]
59. Investigation of Heschl's gyrus and planum temporale in patients with schizophrenia and bipolar disorder: a proton magnetic resonance spectroscopy study. Atagün MI; Şıkoğlu EM; Can SS; Karakaş-Uğurlu G; Ulusoy-Kaymak S; Çayköylü A; Algın O; Phillips ML; Moore CM; Öngür D Schizophr Res; 2015 Feb; 161(2-3):202-9. PubMed ID: 25480359 [TBL] [Abstract][Full Text] [Related]
60. Hippocampal neuronal dysfunction in schizophrenia as measured by proton magnetic resonance spectroscopy. Deicken RF; Zhou L; Schuff N; Fein G; Weiner MW Biol Psychiatry; 1998 Apr; 43(7):483-8. PubMed ID: 9547926 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]